Marguglio David J. 4
4 · Adamis Pharmaceuticals Corp · Filed Mar 19, 2020
Insider Transaction Report
Form 4
Marguglio David J.
Director
Transactions
- Sale
Common Stock
2020-03-18$0.34/sh−10,337$3,479→ 325,022 total
Holdings
- 5,884(indirect: By Children)
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The shares were sold to satisfy the withholding and tax obligations relating to the issuance of shares upon the vesting of RSUs previously granted to the reporting person.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3253 to $0.355, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.